Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 91Rituximab 80Specimen Handling 75Magnetic Resonance Spectroscopy 64Biopsy 59Doxorubicin 48Prednisone 47Vincristine 46venetoclax 38obinutuzumab 35fludarabine 34ibrutinib 29Lenalidomide 29Dexamethasone 27Cytarabine 27Methotrexate 25Etoposide 24prednylidene 23CT-P10 23zanubrutinib 22deltacortene 22blinatumomab 22acalabrutinib 22fludarabine phosphate 21Nivolumab 21merphos 18pembrolizumab 16Bendamustine Hydrochloride 16Mercaptopurine 15Calcium Dobesilate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
carmustine, poliferprosan 20 drug combination × Lymphoid × 30 days × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡